Forcyte Biotechnologies, Inc. was formed to leverage FLECS Technology (originally developed in the Di Carlo Lab @ UCLA) to provide drug-makers and researchers direct access to cellular force generation at the single-cell level – a cellular behavior that was previously inaccessible in an automated way.
We provide a fundamentally new class of cell-based assays that functionally evaluate single-cell contractility, integrated into standard multi-wellplate vessels – available both as end-to-end services, and as consumables.
We perform high-throughout functional contractility measurements in single-cells and multi-cellular structures in vitro in ~384-wellplate formats.
We can perform HTS for effects on contractility in numerous primary cell types using our 200K compound library, or using your compounds
Forcyte Biotechnologies, Inc has not received any reviews.
Forcyte Biotechnologies, Inc has not received any endorsements.